Clinical trial
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in…
NCT00337818 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00337818 |
|---|---|
| Title | Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women |
| Official title | A Long-term, Open, Follow-up of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV-16/18 L1/AS04 Vaccine in Healthy Female Subjects Vaccinated Either Pre- or Post-menarche in the Primary Study |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Papillomavirus Type 16/18 Infection, Cervical Intraepithelial Neoplasia |
| Intervention type | Biological |
| Interventions | Cervarix™ |
| Enrollment | 770 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2006 |
| Completion | Jan 1, 2009 |
| First posted | Jun 16, 2006 |
| Last update posted | May 30, 2017 |
| Countries | Estonia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: